These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1435787)

  • 1. Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity.
    Goffin V; Norman M; Martial JA
    Mol Endocrinol; 1992 Sep; 6(9):1381-92. PubMed ID: 1435787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lactogen receptor-binding site 1 of human prolactin.
    Kinet S; Goffin V; Mainfroid V; Martial JA
    J Biol Chem; 1996 Jun; 271(24):14353-60. PubMed ID: 8662911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells.
    Nickel BE; Kardami E; Cattini PA
    Endocrinology; 1990 Feb; 126(2):971-6. PubMed ID: 2298178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids in highly conserved regions near the C-terminus of rat prolactin (PRL) play critical roles similar to those in binding of human GH to the PRL receptor.
    Kato Y; Maruyama O; Chung HO; Tomizawa K; Kato T
    Biochem Biophys Res Commun; 1996 May; 222(2):547-52. PubMed ID: 8670242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a model to understand prolactin and growth hormone specificities.
    Goffin V; Martial JA; Summers NL
    Protein Eng; 1995 Dec; 8(12):1215-31. PubMed ID: 8869634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
    Peterson FC; Brooks CL
    Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a second receptor binding site on human prolactin.
    Goffin V; Struman I; Mainfroid V; Kinet S; Martial JA
    J Biol Chem; 1994 Dec; 269(51):32598-606. PubMed ID: 7798264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of nine residues at the C-terminus of human prolactin drastically alters its biological properties.
    Goffin V; Struman I; Goormaghtigh E; Martial JA
    Eur J Biochem; 1993 Jun; 214(2):483-90. PubMed ID: 8513798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids in the amino terminal region of the rat prolactin contribute to PRL-receptor binding and NB2 cell proliferation activity.
    Maruyama O; Kato T; Wakabayashi K; Kato Y
    Biochem Biophys Res Commun; 1994 Nov; 205(1):312-9. PubMed ID: 7999042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology modeling of rabbit prolactin hormone complexed with its receptor.
    Halaby D; Thoreau E; Djiane J; Mornon JP
    Proteins; 1997 Mar; 27(3):459-68. PubMed ID: 9094747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.
    Chen WY; Ramamoorthy P; Chen N; Sticca R; Wagner TE
    Clin Cancer Res; 1999 Nov; 5(11):3583-93. PubMed ID: 10589775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the receptor binding and Nb2 proliferation activities of rat prolactin by site-directed mutagenesis.
    Kato Y; Tomizawa K; Kato T
    Zoolog Sci; 1997 Feb; 14(1):147-52. PubMed ID: 9200987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive recombinant methionyl bovine prolactin: structure-function studies using site-specific mutagenesis.
    Luck DN; Gout PW; Beer CT; Smith M
    Mol Endocrinol; 1989 May; 3(5):822-31. PubMed ID: 2666850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.
    Tanaka T; Shiu RP; Gout PW; Beer CT; Noble RL; Friesen HG
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1058-63. PubMed ID: 7419681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity.
    Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A
    Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms.
    Pellegrini I; Gunz G; Ronin C; Fenouillet E; Peyrat JP; Delori P; Jaquet P
    Endocrinology; 1988 Jun; 122(6):2667-74. PubMed ID: 3131120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone.
    Chen TJ; Kuo CB; Tsai KF; Liu JW; Chen DY; Walker AM
    Endocrinology; 1998 Feb; 139(2):609-16. PubMed ID: 9449632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity and immunological reactivity of human prolactin mutants.
    Rhee HK; Sun Z; Kim SS; Goffin V; Martial JA; Dannies PS
    Endocrinology; 1995 Nov; 136(11):4990-5. PubMed ID: 7588233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a motif associated with the lactogenic actions of human growth hormone.
    Peterson FC; Brooks CL
    J Biol Chem; 1997 Aug; 272(34):21444-8. PubMed ID: 9261160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone expression in human Burkitt lymphoma serum-free Ramos cell line.
    Lytras A; Quan N; Vrontakis ME; Shaw JE; Cattini PA; Friesen HG
    Endocrinology; 1993 Feb; 132(2):620-8. PubMed ID: 7678796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.